SLU-PP-332
Also known as: SLU-PP-332
Molecular Overview
SLU-PP-332 is an experimental small-molecule agonist of the estrogen-related receptors (ERRα/β/γ). It has been studied in preclinical models as an 'exercise-mimetic' tool compound in the context of oxidative and mitochondrial metabolism.
Mechanistic Background
Activation of ERRs is associated with programs governing mitochondrial biogenesis and oxidative metabolism; SLU-PP-332 has been used to probe these pathways in experimental systems.
What Researchers Study
Preclinical research has examined effects on energy metabolism, oxidative muscle programs, and exercise-mimetic phenotypes in rodent and cell models.
Evidence Landscape
Current evidence level: PRECLINICAL. Preclinical evidence does not equate to demonstrated human efficacy.
Research Limitations
Evidence is early and preclinical; there is no established human efficacy. It is used as a research tool compound.
Scientific References
Research Use Only
Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.